Panoptix Trifocal Lens in Post Refractive Myopic Laser Vision Correction Surgery

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

March 8, 2021

Primary Completion Date

January 1, 2022

Study Completion Date

July 1, 2022

Conditions
CataractRefractive Errors
Interventions
DEVICE

PanOptix Trifocal Intraocular Lens

This is a FDA approved trifocal lens that will be placed in patients who have had previous myopic LASIK or PRK.

Trial Locations (1)

78229

RECRUITING

Parkhurst NuVision, San Antonio

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Parkhurst NuVision Clinical Research LLC

OTHER

NCT04698278 - Panoptix Trifocal Lens in Post Refractive Myopic Laser Vision Correction Surgery | Biotech Hunter | Biotech Hunter